• Pharmaceutical company Tryp Therapeutics is preparing for clinical trials evaluating synthetic formulations of psilocybin to treat medical conditions with underpinning neurological causes
• The clinical trials planned are being conducted in partnership with research teams at the University of Florida and the University of Michigan
• Tryp executives have been meeting with investors at select conferences recently to increase awareness, including the just-completed Sept. 21 presentation at Oppenheimer’s Fall Healthcare Life Sciences & MedTech Summit
• The company expects to initiate Phase 2a trials to begin before the end of the year for treating certain eating disorders, with Phase 2b trials to follow next year

Novel pharmaceutical company Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) continues to garner attention for its development of psilocybin as potential treatments for medical conditions with largely unmet needs, presenting an overview of its business and ongoing clinical trials for its two trademarked drug candidates most recently at the Oppenheimer Fall Healthcare Summit. Tryp is nearing the launch of a Phase 2a clinical trial that aims to establish the value of its psychedelic drug candidate, TRP-8802, in treating chronic and severe eating disorders such as Prader-Willi Syndrome (PWS), hypothalamic obesity disorder resulting from the removal of a brain tumor, and binge eating dysfunction. The company also plans to execute Phase 2b clinical trials for its proprietary psychedelic candidate TRP-8803 to evaluate its ability to penetrate the natural blood-brain barrier and effectively alleviate pain and addiction concerns, including targets for phantom limb pain and fibromyalgia. Oppenheimer’s Fall Healthcare Life Sciences & MedTech Summit featured companies’ presentations and one-on-one meetings by invitation only through a virtual platform online. Tryp joined other select public companies in the sector for a presentation that paired investors with management teams to discuss key programs in detail, delivering its address on Sept. 21 (https://ibn.fm/30YVm). The management team also presented an overview of the company the prior week at the H.C. Wainwright 23rd Annual Global Investment Conference and at the Canaccord Genuity Virtual Growth Conference last month. “I am excited to showcase the transformative work that Tryp Therapeutics is doing in collaboration with our academic research partners such as the University of Michigan and the University of Florida,” Tryp Chairman and CEO Greg McKee stated in July (https://ibn.fm/P8zw8). “The next six months represent an important stage in development for us as we initiate multiple Phase 2a clinical trials and move closer to providing additional treatment options for the millions of patients suffering from a variety of chronic pain diseases and eating disorders.” Tryp’s product development moves beyond the initial interests in testing psychedelics for treating solely mental health issues such as depression, anxiety, addiction, and PTSD, combining supervised administration of the drug with psychotherapy in response to select medical conditions in which specific neurological maladies play a causal role. Tryp also is distinguishing itself by developing a novel method of administration for its TRP-8803 candidate to make the experience better for patients, leading to a provisional patent to protect the unique features of the proprietary formulation. The company’s drug products are manufactured in the United States as part of an exclusive supply chain for its active ingredients that assures Tryp will have sufficient quantities to complete its clinical trials and establish eventual commercialization. Tryp expects Phase 2a trials for the eating disorders and for phantom limb pain to begin before the end of the year (https://ibn.fm/finBj). For more information, visit the company’s website at www.TrypTherapeutics.com. NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

• SGMD anticipates using the licenses for three new vertically integrated Nug Avenue cannabis delivery hubs
• Each of the licenses can be used for up to three of five categories of licensed cannabis-related business activities
• Definitive agreement aligns with announcement that Sugarmade has acquired LA property for first of new Nug Avenue cannabis delivery hubs

In its continued focus on building is cannabis delivery interests, Sugarmade (OTC: SGMD) has signed a definitive agreement to obtain three nonstorefront California cannabis licenses from the Los Angeles Department of Cannabis Regulation (“DCR”), along with corresponding licenses from the California Bureau of Cannabis Control (“BCC”) (https://ibn.fm/EyI3W). SGMD is focused on establishing itself as a leader in California’s vertically integrated cannabis marketplace, and the company anticipates using the licenses for its planned three new vertically integrated Nug Avenue cannabis delivery hubs. “Once we have put all of these new licenses to use, we will have quadrupled our distribution footprint in the world’s largest cannabis market,” said Sugarmade CEO Jimmy Chan. “We also continue to move toward establishing our own cultivation operations. Together, these steps are part of our core vision – to establish a full farm-to-door vertically integrated cannabis company capable of driving a much greater percentage of total sales to the bottom line for our shareholders, while capturing much greater control over product quality for our customers.” According to the announcement, each of the three licenses that SGMD plans to acquire can be used for up to three of the five categories of licensed cannabis-related business activities allowed under the terms of these licenses: retail delivery, manufacturing, distribution, transport-only, and cultivation. The company noted that by using each license for a combination of retail delivery of cannabis products with supply chain distribution of cannabis products and manufacturing/packaging of cannabis products, it will possess the required licensing to open three new Nug Avenue locations; the company plans on opening the new operations in the Los Angeles metropolitan area. The signing of the definitive agreement aligns ideally with the company’s announcement that it has acquired a property in Los Angeles that will serve as the first of these new Nug Avenue cannabis delivery hubs. SGMD’s initial involvement in Nug Avenue came as a result of an agreement announced in February, in which the company acquired a 70% stake in the Lynwood, California, operations of Nug Avenue. Based on the agreement, SGMD will recognize 100% of revenue and 70% profits generated from Nug Avenue’s Lynwood delivery service operations. In addition. Those same terms will carry over to each new Nug Avenue location as the company expands. Sugarmade Inc. is a product and branding marketing company investing in operations and technologies with disruptive potential. In addition to its financial interest in the BudCars brand, SGMD’s brand portfolio includes Nug Avenue, CarryOutsupplies.com, SugarRush(TM) and Lemon Glow. For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

• New director will add significant strength to business development and marketing initiatives
• Davis has decades of sales and business development experience heavily focused on emerging technology solutions for telecommunications, utilities industries
• StorEn focused on revolutionizing the world of residential, industrial energy storage

StorEn Technologies, a developer of evolutionary vanadium flow batteries with a disruptive patent-pending, all-vanadium flow battery technology, has named John Davis as its new director of business development (https://ibn.fm/XkKIa). Davis is a seasoned executive with almost three decades of experience in sales and business development. “The appointment will add significant strength in our business development and marketing initiatives, in our core areas of focus such as residential storage, telecoms and other key segments, in North America and internationally,” the company announced. “John has over 28 years executive level experience in sales and business development heavily focused on emerging technology solutions for the telecommunications and utilities industries. “Most recently, John held the position of director of business development for XNRGI Inc, an early-stage lithium battery developer building an innovative solid state lithium battery technology,” the announcement continued. “Over the course of the last 20 years, John has worked with a number of flow battery and fuel cell developers including ZincNyx, RedFlow Limited, Deeya Energy, VRB Power, ReliON Fuel Cells and Metallic Power.  During his time at VRB, one of the first vanadium flow battery companies, John oversaw the sales and delivery of the first flow battery installed at a telecom site.” The company noted that Davis has played an instrumental role in the standardization of hydrogen fuel cells used as stationary backup power at many telecom sites throughout the United States and the Caribbean. In addition, Davis held the position of senior director of European Sales with Tekelec Inc. in the mid-1990’s, overseeing an extensive distribution network in 15 countries. StorEn has developed evolutionary vanadium flow batteries. Incubated at the Clean Energy Business Incubator Program (“CEBIP”) within Stony Brook University in New York, the company is building upon the strengths of vanadium flow batteries to revolutionize the world of residential and industrial energy storage. In part, StorEn’s technology has enhanced the electrical efficiency of the stack and energy density of the electrolyte and module, ultimately reducing costs and improving performance. The company produces products with a battery life of 25 years and more than 15K cycles. That company takes pride in offering batteries that meet consumers demand for efficient, durable and cost-effective energy storage, enabling self-consumption of self-produced electricity and the transition toward a carbon-free economy. StorEn is in the process of a RegA offering with four different investment tiers; each tier offers a different discount and reward (https://ibn.fm/E4IcJ). With a proprietary product that answers the call for long-lasting, 100% recyclable, safe and affordable energy storage, StorEn and its disruptive, patent-pending, all-vanadium flow battery technology for energy storage holds real promise in a growing market. For more information, visit the company’s website at www.StorEn.tech. NOTE TO INVESTORS: The latest news and updates relating to StorEn Technologies are available in the company’s newsroom at https://ibn.fm/StorEn

• Statista report notes that the global cannabidiol market size is expected to expand at a compound annual growth rate of 21.2% from 2021 to 2028
• Increasing awareness of CBD’s therapeutic benefits have influenced buyers to buy cannabidiol products, regardless of their cost
• Simply Sonoma, a CBD company focused on building a reputation as a leader in plant-based medicinal health and beauty products

A recent Yahoo.finance article touted the growth of the CBD market, a sector that has seen steady growth even during the pandemic (https://ibn.fm/19R2d). Titled “CBD Market to Grow to $16 Billion by 2026 — Should You Invest?,” the article reports the projected billion-dollar growth of the CBD space, growth that Simply Sonoma, a company committed to organic farming, is primed to benefit from. “The global cannabidiol market size was valued at $2.8 billion in 2020 and is expected to expand at a compound annual growth rate of 21.2% from 2021 to 2028, according to a Grand View Research report,” the Yahoo article reported. “In addition, sales of CBD products in the U.S. stood at $4.6 billion dollars in 2020, and by 2026, this market is expected to grow to $16 billion dollars in value, according to a Statista report. “Increasing awareness of CBD’s therapeutic benefits have influenced buyers to buy cannabidiol products, regardless of their cost, according to the report,” the article continued. “In turn, as these have a greater profit margin, commercial retailers, including health and wellness retailers such as Rite Aid, CVS Health and Walgreens Boots Alliance, are now focusing on selling CBD products.” The growing awareness and popularity of CBD is especially evident in California. “With estimated sales of $730 million, the state of California is the country’s leading market for CBD products,” stated the article, which also noted the growing variety of CBD products available. “‘CBD products come in many different shapes and sizes, including tea, vape products and soaps. Within the food segment, oils and spreads were the most common types of cannabidiol products in 2019,” according to Statista. “‘In American convenience stores, vitamins were the leading CBD segment in terms of sales, generating over 20 million U.S. dollars in 2020. Overall, lotions and balms were the segment of CBD products that sparked the most interest among consumer[s] in the U.S. followed by gummies, tinctures, and supplements. While still a relatively small factor in consumer markets, CBD penetration is growing. In 2019, CBD accounted for four percent of the global vitamin and dietary supplements market. By 2027, this number is expected to grow to over 20 percent,’” the article concluded. Those are exciting numbers for Simply Sonoma, a CBD company focused on building a reputation as a leader in plant-based medicinal health and beauty products. Specifically, Simply Sonoma is developing broad-spectrum CBD products for therapeutic applications from a scientific perspective. Its products come from the farm rather than from a lab, with the goal of achieving fewer side effects and more efficacy for patients. The company is committed to incorporating published, science-based trials and research into the formulation and manufacture of its CBD offerings. Simply Sonoma is a different kind of natural company and looks forward to introducing its exceptional products to the consumer market. For more information, or to invest in Simply Sonoma, visit the company’s website at www.SimplySonoma.org. NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma are available in the company’s newsroom at https://ibn.fm/Sonoma

• On August 3, 2021, Infobird signed a service contract with a subsidiary of a global leading retail brand
• The brand is a Fortune 500 retail and consumer product company and a leader in its sector, with operations in over 80 countries around the world
• It hopes that through this contract it will capitalize on Infobird’s intelligent quality inspection to improve its customer service system within the Chinese market
• This move demonstrates Infobird’s commitment to improving what it offers and successfully expanding into the market of retail and consumer product companies

On August 3, 2021, Infobird (NASDAQ: IFBD) announced that it had signed a service contract with a subsidiary of a global leading retail brand (https://ibn.fm/7cclL). This Fortune 500 retail and consumer product company is a leader in its sector and has operations in over 80 countries worldwide. It hopes that, through this contract, it will capitalize on Infobird’s intelligent quality inspection in a bid to significantly improve its customer service system within the Chinese market (https://ibn.fm/Fxs8C). It also hopes to bring users the ultimate consumer experience by creating caring, convenient, and professional customer services. Infobird is a software-as-a-service (“SaaS”) provider, offering artificial intelligence (“AI”)-powered customer engagement solutions for the Chinese market. Since it was founded in October 2001, this company has always sought to bring value to its clients with solutions to increase revenue, enhance service quality, reduce overheads, and improve customer satisfaction. It leverages an in-house cloud computing structure, AI, and machine learning capabilities to serve its client base that is steadily growing. Infobird trusts that its intelligent quality inspection system will help the company achieve 100% coverage and automation of intelligent quality inspection with this collaboration. It also believes that the system will allow the company to optimize the scope of quality inspection channels, customer service soft power, and speech flow, among various other aspects. So far, Infobird’s technology and solutions for the retail and consumer product industry have been applied in various leading companies such as SaSa, a beauty brand based in Hong Kong, and Zu Li Jian, a footwear company for the elderly in China. Its solutions cover various business scenarios, including but not limited to management, marketing, and customer service. For an industry that is proliferating, Infobird has positioned itself perfectly, and this cooperation is another breakthrough in Infobird’s market development strategy in the retail and consumer product industry. Following the pandemic, retail and consumer products introduced a historic development opportunity and sparked a growth which McKinsey & Company projects will continue, particularly in the Chinese market. In just the first half of 2021, total retail sales of consumer products in the Chinese market were over 21.2 trillion yuan, a 23% growth from the same period in 2020 and an average growth rate of 4.4% over the past two years. One central draw point from this growth is the role that digitalization of customer engagement is playing. More companies are optimizing their customer engagement process to enhance the customers’ experience through technology and business model upgrades. Infobird understands these trends, goals, and requirements, hence its investment into the technology and services it offers. The successful client launch with this global leading retail brand demonstrates Infobird’s commitment to improving what it offers and successfully expanding into the market of retail and consumer product companies. For more information, visit the company’s website at www.Infobird.com/en/index.html. NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

• FuelPositive CEO Ian Clifford was featured in a recent Stock2Me Podcast episode
• Clifford noted that the company is at the forefront of developing the dialog around adaptable carbon-free NH3 and is taking a thought leadership stance in that space
• In April 2021, FuelPositive purchased a cutting-edge technology designed to produce carbon-free ammonia in a scalable, modular, and economically viable fashion
• The company is currently manufacturing the demonstration units for this patent-pending technology and is planning demonstration programs aimed at showcasing the technology’s real-life applications initially in the agriculture sector
• FuelPositive is also targeting the transportation sector as well as hydrogen storage

Toronto-based FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is looking to change the energy landscape through its flagship project, which entails using its proprietary, first-of-its-kind technology to produce carbon-free ammonia (“NH3”) in a scalable, modular, environmentally sound, and economically viable fashion. NHHHF is targeting three primary segments – agriculture, transportation, and energy storage – all in an effort to significantly reduce carbon dioxide (“CO2”) emissions from human activities, so far, the single largest contributor to global warming. According to FuelPositive CEO Ian Clifford, who was speaking in a recent Stock2Me Podcast episode hosted by Stuart Smith, the company purchased this cutting-edge technology, whose use will herald a departure from how NH3 is currently synthesized, in April this year (https://ibn.fm/dWjjL). Today, the industrial synthesis of NH3 through the Haber-Bosch process is one of the most “carbon-intense processes on the planet” – producing one ton of NH3 emits about 2 tons of CO2, translating to 1.44% of total Co2 emissions globally. In addition, the process is energy-intensive, using up 1-2% of the world’s total energy production (https://ibn.fm/T9qCE). Clifford observed that these disadvantages have historically meant that NH3 could not be recognized as a viable fossil fuel replacement, but the company’s technology is looking to change that narrative. “Our system is entirely carbon-free,” said Clifford. “We take sustainable electricity, water, and air, and we produce carbon-free NH3, which can be utilized across multiple industries as an extremely versatile material… We are now just in the process of commercializing the technology, and we plan to have demonstration units ready and out there in the real world early in 2022.” The demonstration units, currently in the manufacturing stage with National Compressed Air in Toronto, will enable FuelPositive to showcase real-world applications for the technology. To this end, the company is focused on determining and putting in place the best, highest-profile demonstration programs possible early in 2022. It is working with the Sussex Group, a government relations group based in Ottawa and Toronto, to ensure it has the best and highest visibility for the demonstration programs. FuelPositive will initially focus these demonstration programs on agriculture, as the sector already understands the importance of NH3 as a fertilizer – about 80% of the NH3 produced is used as fertilizer, either for direct application or conversion into nitrogen fertilizer. “Our demonstration projects initially in agriculture would see a farm that utilizes NH3 today having a FuelPositive system installed on the farm, utilizing sustainable electricity… and producing all of the NH3 they need for fertilizer requirements for their farm,” Clifford continued. “Add to that this incredible versatility of NH3, that the NH3 molecule is more than just a fertilizer – it’s a fossil fuel replacement fuel, it’s a very effective refrigerant, and it’s a very important chemical in a lot of other processes.” According to Clifford, the farm can use the onsite technology to produce carbon-free NH3 (1) for its fertilizer needs, (2) to power its tractors and combine harvesters, and (3) as a propane replacement in the crop-drying systems. FuelPositive’s technology will also substantially benefit farmers by helping them decarbonize as well as reduce their reliance on existing fertilizer and fossil fuels supply chains, which increase their vulnerability to erratic price changes. Additionally, being modular and scalable, the technology is ideal for both large and small farms. With a focus on the transportation sector, which in 2019 accounted for 24% of the direct C02 emissions from fuel combustion globally (https://ibn.fm/YZdhS), FuelPositive is targeting pure carbon-free transportation solutions. It aims to achieve this by replacing fossil fuel products – gasoline and diesel – with carbon-free NH3 in converted internal combustion engines. Notably, upon proper combustion, carbon-free NH3 only emits steam/water vapor. FuelPositive also intends to use carbon-free NH3 as the perfect carrier for hydrogen (“H2”) in the hydrogen economy, given that NH3 is the most hydrogen-dense material on the planet and is easier to store than H2. “When you start looking at the viability of H2 fuel cells and H2 combustion down the road, the real answer to the via this is carbon-free NH3,” Clifford explained. “Green NH3 is an enabler for the hydrogen economy. So, there is a very significant role for NH3 in the future of hydrogen.” To listen to the whole podcast, please visit https://ibn.fm/8Ssc8 For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• A 2020 Deloitte China report noted that big data will be vital in ensuring insurance survive for longer post-pandemic and accelerate their transformation towards excellence
• Big data is instrumental in facilitating greater product innovation and pricing accuracy for insurers
• Through its Big Data Insights division (Sapientus), FingerMotion appears well positioned as an ideal partner for insurers looking to implement Deloitte’s proposals
• The China Banking and Insurance Regulatory Commission recently scrapped the 51% cap on foreign ownership, setting the stage for potential growth of the country’s insurance sector

Last year, Deloitte China released a report titled “COVID-19 and China’s Insurance Industry” that explored the measures insurers have taken to deal with the pandemic, the macro impact of COVID-19 on the insurance industry, and, lastly, how insurance companies should accelerate their transformation towards excellence (https://ibn.fm/U2kpn). The report noted that big data, which some insurers were already using as early as February 2020, will be instrumental in the post-pandemic insurance world. According to Deloitte China, the pandemic posed a significant challenge to the adaptability and resilience of insurance companies and their management teams. This means that these firms need to consider building sustainable management systems to ensure longevity moving forward. The report proposed that insurers should apply big data to facilitate product differentiation and build digital operational capabilities. With mechanisms already in place, having launched its Big Data Insights division (Sapientus) in July 2020 and subsequently partnered with Pacific Life Re-Insurance, evolving technology company FingerMotion (OTCQX: FNGR) appears poised as an ideal partner for insurers looking to implement Deloitte China’s proposals. Speaking in an August 25 corporate update, FingerMotion CEO Martin Shen noted that Sapientus stands out because of its ability to integrate publicly available data into proprietary risk matrices with behavioral indicators derived from event-driven or contextual-based information. Through the provision of behavioral analytics, FNGR is looking to supply actionable intelligence and enable efficient service delivery to potential clients within the insurance industry (https://ibn.fm/I1Nhu). Incidentally, the Deloitte report had alluded to this particular application of big data. It recommended that insurers should make full use of data from external and internal sources to “facilitate quantitative models for customer segmentation, and thus more accurate pricing and greater product innovation.” FingerMotion’s efforts in the insurance sector coincide with a recent move by the China Banking and Insurance Regulatory Commission (“CBIRC”) to scrap the 51% cap on foreign ownership in insurance businesses in a bid to open up the domestic insurance market and expand the sector (https://ibn.fm/WJ936). In its analysis, Mordor Intelligence quoted the resultant potential increase in the number of insurance companies in China due to CBIRC’s move as one of the factors expected to help the sector grow even further. The market research company projects that China’s life and non-life insurance market will grow at a 6% CAGR from 2020 to 2025 (https://ibn.fm/jCqxM). At the same time, the online insurance market is expected to grow at a 41% CAGR from 2019 through 2024 (https://ibn.fm/9O90d). FingerMotion is a technology company with core competencies in SMS/MMS services, mobile payment and recharge solutions, and big data insights. It is also targeting the burgeoning rich communication services (“RCS”) segment, with the expectation that RCS will form the company’s fourth division once launched. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

ACP created a cash flow positive model that protects shareholders Privately owned American Cannabis Partners (“‘ACP”), a multistate operator creating a sustainable Jamaican cannabis experience, has created a cash flow positive business model that protects shareholders and the company regardless of the fluctuations in the industry. ACP’s CEO, Stephen Jordan worked in the cannabis business for three years in Jamaica. He brought those relationships, and employees with 30-40 years of experience in cultivation, back with him to California when recreational cannabis became legal in 2018. The company currently operates in Northern California and Michigan with plans to expand into a third state within the next year. Tangible assets like real estate and equipment play a key role in creating stability for ACP before building the company out. They have acquired 11 cultivation licenses, one retail license, and have around 560,000 square feet of canopy space for cultivation. This provides the safety net to liquidate if necessary to stay in business while also protecting shareholders. ACP will remain cash flow positive as they move forward into their projected third U.S. state in 2022 and a fourth in 2024. Assets and safety are essential values to the company, and, says Jordan, “That’s one of the hardest things to find in this industry. A lot of people and a lot of companies have products, but they’ve placed themselves in very strenuous liability situations. If they can’t make a product, they no longer have a company. ACP took the opposite direction” (https://ibn.fm/S0VV8). The company’s “asset and safety strategy” is to acquire real estate and licenses in states that have newly passed cannabis legalization. This allows them to capitalize on Federal interstate commerce opportunities. Additional strategies are in place to capture the growth of emerging medical and recreational commercial markets. Concern for the shareholder’s safety highlights the company’s overall care for others. A recent article shares what ACP refers to as its triple bottom line and goal to positively impact people (as a high-paying grower), the planet (100% organic material), and profits (through assets and safety) (https://ibn.fm/iMcpx). The people will always come first. This is seen most clearly in ACP’s continued commitment to the needs of Jamaica and its people. In addition to cultivation and real estate, ACP is focused on medical research. The company’s newly added medical director, Jeereddi A. Prasad, M.D., is responsible for placing physicians of various specialties in direct interaction with cultivators, to genetically steer plants for volunteer clinical research studies that focus on PTSD, Parkinson’s, and other conditions. This is a company worth watching as they continue to spread out across the U.S., maintain the status as a high-paying grower, while remaining environmentally friendly and cash positive. For more information, visit the company’s website at www.ACPFarms.com. NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://ibn.fm/ACP

• Flora Growth Corp., a cannabis company with low-cost cultivation and global distribution, recently reached a non-binding LOI with Panamanian importer and distributor Robust Farms Inc. to supply product from its portfolio
• Panama is a country on the verge of opening to medical marijuana sales and the first in Central America to open a regulated market following legislation approved without a dissenting vote by the National Assembly
• Flora Growth maintains a large licensed outdoor operation in Colombia, from which it cultivates cannabis that will be used in a variety of branded products
• Flora Growth has been increasing its international outlets, including an agreement with Hoshi International Inc. expected to open up numerous opportunities in the European Union

On the heels of news that Panama’s National Assembly congress passed legislation legalizing medical marijuana (https://ibn.fm/gfh8W), internationally focused cannabis cultivator and brand builder Flora Growth (NASDAQ: FLGC) is generating excitement through the establishment of a non-binding LOI with Panamanian importer and distributor Robust Farms Inc. to supply its premium cannabidiol (“CBD”)-derivative products. Panamanian President Laurentino Cortizo is expected to sign the legislation despite a veto campaign from the conservative political opposition, which will make Panama the first Central American nation to regulate the leafy green plant following decades of drug war rhetoric against cannabis and its marijuana product (https://ibn.fm/QOueo). Flora Growth will provide Panama’s Robust Farms with cannabinoid-containing food and beverages through its Kasa Wholefoods division, according to the company, once Robust’s cannabis import licensed is approved. Flora will also provide finished medical-grade cannabis products for patients under the expected regulatory framework. “We’re extremely pleased to enter into this agreement with Flora in order to pre-emptively secure access to their medical-grade cannabis products — which we believe is the first of its kind to be announced since the cannabis legislation passed — and look forward to supplying our clients with Flora’s premium portfolio of CBD-infused and non-CBD food and beverage products in the short term,” Robust CEO Maurice Holmes Mendez stated in the news release about the LOI (https://ibn.fm/OALh6). “While the new proposed framework awaits signature from the President, our team is hard at work building out our traditional and medical cannabis sales channels in the LATAM region, which relies heavily on working with experienced business partners and healthcare practitioners,” Mendez added. Flora Growth is headquartered in Canada, with its sights on relocating offices to the United States and core product cultivation operations in Colombia. The company’s end user markets include Australia and various countries in Latin America, Europe and Asia, demonstrating its global reach. The company’s European expansion plans are being advanced through the recent closure of a €2 million investment in Hoshi International Inc. — a fully integrated cannabis company with strong experience in working in the European market (https://ibn.fm/p7az0). Germany, which leads the European cannabis market in terms of growth, completed an estimated €111 million in medical cannabis trade between January and September of last year, with flower sales making up about 48.6 percent of the market, according to the Hoshi investment announcement. For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• • Nug Avenue has picked up more than 10,000 new unique members as of the end of June, significantly exceeding initial projections
  • Sugarmade has opened an escrow account for the purpose of acquiring property in California to be used for delivery hub
  • SGMD has taken steps toward making an offer on licenses for the state of Oregon
  A growing cannabis delivery service, new commercial licenses and expansion into Oregon were highlights of a recent update provided by Sugarmade (OTC: SGMD). The emerging leader in the vertically integrated California cannabis marketplace released an update for current and prospective shareholders containing details of these key milestones in the company’s strategic plan (https://ibn.fm/um1TT). “Sugarmade. . . is pleased to update current and prospective shareholders on the Company’s growing Nug Avenue operations, as well as further strides toward verticalizing its model through the acquisition of California cannabis licenses and potentially establishing commercial operations in the cannabis delivery market outside of the state of California,” the report stated. “We continue to make tangible strides toward a vertically integrated model,” noted Sugarmade CEO Jimmy Chan. “Our long-term strategic vision is to establish the capacity to control all aspects of production, supply, manufacturing, packaging, distribution and delivery — to become a true ‘farm-to-door’ cannabis company. This vision should provide for better unit economics, margin growth and gains in product quality and customer satisfaction. Organic brand growth, property acquisition, licensing and geographic expansion are all important steps toward achieving that vision for Sugarmade and its shareholders.” Regarding Nug Avenue, the report noted that the company had established its initial Nug Avenue cannabis delivery operation in March 2021. Since that official launch, the operation has grown substantially, picking up more than 10,000 new unique members as of the end of June, a number that significantly exceeded the company’s internal projections. “We will have more details on Nug Avenue performance soon, but we wanted to report our strong progress and let our shareholders know that we are quickly establishing a brand presence in the Los Angeles cannabis delivery market at our first location, which should carry over to help in establishing rapid customer growth in new locations as we expand,” noted Chan. As for commercializing new licenses, the update reported that Sugarmade has officially opened an escrow account for the purpose of acquiring property. The company plans to use the property for one of three new non-storefront California cannabis licenses it is in the process of acquiring. In June 2021, Sugarmade announced that it had signed a memorandum of understanding to obtain three non-storefront California cannabis licenses from the Los Angeles Department of Cannabis Regulation, along with corresponding licenses from the California Bureau of Cannabis Control, which collectively provide the licensing foundation for the opening of three new Nug Avenue cannabis delivery hubs in the Los Angeles metro area. Finally, the update reported that the company has taken steps toward making an offer on licenses for the state of Oregon; purchase of property may or may not include a real estate purchase in the process. “This is a step toward potentially establishing cannabis delivery operations in Oregon,” the update stated. “The Oregon recreational cannabis market is one of the largest and fastest-growing in the country, with total sales expected to top $1 billion this year.” Sugarmade has reached out to local service providers to move this expansion process forward, with further details expected to be released soon. Sugarmade Inc. is a product and branding marketing company investing in operations and technologies with disruptive potential. In addition to its financial interest in the BudCars brand, SGMD’s brand portfolio includes NUG Avenue, CarryOutsupplies.com and SugarRush. For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD